Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera | |'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera | ||
|Fabiola Quintero-Rivera (FQR) | |Fabiola Quintero-Rivera (FQR) | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 37: | Line 37: | ||
|T. Niroshi Senaratne | |T. Niroshi Senaratne | ||
|FQR | |FQR | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 76: | Line 76: | ||
|Shashi Shetty | |Shashi Shetty | ||
|FQR | |FQR | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 89: | Line 89: | ||
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff | |'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff | ||
|FQR | |FQR | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 582: | Line 582: | ||
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi | |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 588: | Line 588: | ||
| Monoclonal B-cell Lymphocytosis||Disease||Honey Reddi | | Monoclonal B-cell Lymphocytosis||Disease||Honey Reddi | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 594: | Line 594: | ||
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi | |B-cell Prolymphocytic Leukemia||Disease||Honey Reddi | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 612: | Line 612: | ||
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel | |'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
|Malini to review | |Malini to review | ||
| Line 618: | Line 618: | ||
| Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel | | Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
|Malini to review | |Malini to review | ||
| Line 630: | Line 630: | ||
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi | |Lymphoplasmacytic Lymphoma||Disease||Honey Reddi | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 636: | Line 636: | ||
| Waldenstrom Macroglobulinemia||Disease||Honey Reddi | | Waldenstrom Macroglobulinemia||Disease||Honey Reddi | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 667: | Line 667: | ||
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang | |Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 673: | Line 673: | ||
| Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang | | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 679: | Line 679: | ||
| Plasma Cell Myeloma||Disease||Zhenya Tang | | Plasma Cell Myeloma||Disease||Zhenya Tang | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 685: | Line 685: | ||
| Plasma Cell Myeloma Variants||Disease||Zhenya Tang | | Plasma Cell Myeloma Variants||Disease||Zhenya Tang | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 691: | Line 691: | ||
| Plasmacytoma||Disease||Zhenya Tang | | Plasmacytoma||Disease||Zhenya Tang | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 727: | Line 727: | ||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 778: | Line 778: | ||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari | |Mantle Cell Lymphoma||Disease||Mahsa Khanlari | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 784: | Line 784: | ||
| Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari | | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 790: | Line 790: | ||
| In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari | | In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 860: | Line 860: | ||
|- | |- | ||
|Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC | |Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC | ||
| | |Complete | ||
| | | | ||
| | | | ||
| Line 930: | Line 930: | ||
|- | |- | ||
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP | |T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
|- | |- | ||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP | |T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
|- | |- | ||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP | |Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 986: | Line 986: | ||
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan | |'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 992: | Line 992: | ||
| Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan | | Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 998: | Line 998: | ||
| Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara | | Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 1,004: | Line 1,004: | ||
| Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan | | Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 1,010: | Line 1,010: | ||
| Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan | | Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
|- | |- | ||
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP | |Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 1,101: | Line 1,101: | ||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara | |Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 1,107: | Line 1,107: | ||
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara | |Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 1,113: | Line 1,113: | ||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara | |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara | ||
|SP | |SP | ||
| | |PENDING | ||
| | | | ||
| | | | ||
| Line 1,181: | Line 1,181: | ||
Fabiola Quintero-Rivera | Fabiola Quintero-Rivera | ||
| | | | ||
| | |PENDING | ||
| | | | ||
| | | | ||